Objective: Reduced nephron number is hypothesized to be a risk factor for chronic kidney disease and hypertension. Whether reduced nephron number accelerates the early stages of diabetic ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Scientist develop new equation for detecting hyperfiltration that incorporates age but not body surface area. Read more!

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- “Yo-yo” dieting -- repeatedly losing and gaining weight -- can significantly ...

The researchers tested PEITC in rats that had diabetic nephropathy. Their results showed evidence that PEITC may help repair ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...

Research shows that body-weight cycling significantly increases the risk of kidney disease in individuals with Type 1 ...